PLEKHA8 and hepatocellular carcinoma: Our results thus demonstrate that a PLEKHA8P1-PLEKHA8 axis could exert a cytoprotective effect against 5-FU, thus connoting both molecules as novel therapeutic targets in HCC-related chemoresistance studies.